Dermatology News and Research

Latest Dermatology News and Research

$Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS$

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

Upsher-Smith Laboratories, Inc. today announced the successful completion of its global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using the company's proprietary formulation technology.

23 May 2013

Choosing better sunscreen to protect family members

Like most over-the-counter products, not all sunscreens are created equal. Some sunscreens provide higher sun protection, while others contain ingredients that are better suited for children's skin. The key is choosing a sunscreen that will provide the best sun protection for all family members, and combining sunscreen use with other sun-smart behaviors.

21 May 2013

Patient compliance: an interview with Dr. Bassam Damaj, CEO of Innovus Pharma

A medication’s optimal results are achieved with specific dose levels and times of administration. In order for patients to achieve the maximum benefit from a medication, they have to adhere to the prescribed dose and time of use.

20 May 2013

Researchers explain why cost of care higher for men with severe psoriasis

Men often suffer from more severe cases of psoriasis than women, which may explain why the cost of care for men is higher. This is the conclusion of researchers at Umeå University in a new study.

16 May 2013

Headline results of Creabilis' CT327 Phase 2b trial in psoriasis patients announced

Creabilis, a late stage European dermatology company with a focus on chronic pruritus (itch), today announces headline results of its Phase 2b trial with its lead product, CT327, in psoriasis patients.

10 May 2013

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that the European Patent Office has issued a notice of Intention to Grant a European Patent that provides protection for the Company's PENNSAID 2% product.

9 May 2013

GHS patients to have access to doctors' notes through MyGeisinger online patient portal

More than 100,000 Geisinger Health System patients will have access to their doctors' notes for the first time through the secure MyGeisinger online patient portal when Geisinger expands OpenNotes in May due to the initiative's overwhelming success.

9 May 2013

Idera to present data from Phase 2 trial of IMO-3100 in patients with psoriasis at IID 2013

Idera Pharmaceuticals today announced presentation of data from its randomized, double-blind, placebo-controlled Phase 2 trial that showed improvements from baseline of up to 90% in Psoriasis Area Severity Index scores in patients with moderate to severe plaque psoriasis following four weeks of treatment with the Toll-like Receptor antagonist IMO-3100.

8 May 2013

FDA warns over the use of sunlamp products that cause skin cancer

Today, the U.S. Food and Drug Administration issued a proposed order that, if finalized, would reclassify sunlamp products and require labeling to include a recommendation designed to warn young people not to use these devices.

7 May 2013

AADA urges FDA to prohibit the use and sale of indoor tanning devices for minors

The American Academy of Dermatology Association (AADA) is pleased that the U.S. Food and Drug Administration (FDA) has proposed changes to its regulation of tanning beds, including a strong recommendation against the use of tanning beds by minors under the age of 18.

7 May 2013

Nuvo Research intends to proceed with its proposed share consolidation

Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.

7 May 2013

Loyola takes steps to educate children about sun safety

Having one blistering sunburn in childhood or adolescence more than doubles a person's chance of developing melanoma later in life, yet less than one-third of all young people take the proper steps to protect their skin from excessive sun exposure, according to the Skin Cancer Foundation.

3 May 2013

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from AUGMENT/COPD, the second six-month pivotal phase III clinical trial evaluating the efficacy and safety of investigational fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) for the treatment of Chronic Obstructive Pulmonary Disease (COPD), delivered in the Pressair™ inhaler (Genuair® outside the USA).

2 May 2013

Forest Laboratories, Almirall report positive topline results from AUGMENT COPD

Forest Laboratories, Inc. and Almirall, S.A. today announced positive topline results from AUGMENT COPD, the second six-month pivotal phase III clinical trial evaluating the efficacy and safety of investigational fixed dose combinations of aclidinium bromide and formoterol fumarate, delivered in the Pressair (Genuair outside the USA) inhaler.

2 May 2013

Dermatology News and Research

Latest Dermatology News and Research

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

Choosing better sunscreen to protect family members

Patient compliance: an interview with Dr. Bassam Damaj, CEO of Innovus Pharma

Researchers explain why cost of care higher for men with severe psoriasis

Headline results of Creabilis' CT327 Phase 2b trial in psoriasis patients announced

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

GHS patients to have access to doctors' notes through MyGeisinger online patient portal

Idera to present data from Phase 2 trial of IMO-3100 in patients with psoriasis at IID 2013

FDA warns over the use of sunlamp products that cause skin cancer

AADA urges FDA to prohibit the use and sale of indoor tanning devices for minors

Nuvo Research intends to proceed with its proposed share consolidation

Loyola takes steps to educate children about sun safety

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

Forest Laboratories, Almirall report positive topline results from AUGMENT COPD

Experts call for medical leaders to establish guidelines, embed honesty in academic cultures

Academy asks public to wear orange in support of skin cancer awareness on Melanoma Monday

Golfers may be at risk for skin cancer, say LUHS dermatologists

UCSF study focuses on vexing problems of handling skin cancers among elderly patients

Biventricular pacing best in atrioventricular block patients

Kidney disease screening needs rethink in hypertension

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dermatology News and Research

Latest Dermatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in